System and methods for performing saliva-based diagnostic screenings
US-2024420847-A1 · Dec 19, 2024 · US
US2016274128A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016274128-A1 |
| Application number | US-201615174559-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jun 6, 2016 |
| Priority date | Jan 17, 2013 |
| Publication date | Sep 22, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using a measured urine concentration of one or more of TIMP2 and IGFBP7 in combination with one or more of a measured serum creatinine and a measured urine output, which results are correlated to the renal status of the subject, and can be used for diagnosis, prognosis, risk stratification, staging, monitoring, categorizing and determination of further diagnosis and treatment regimens in subjects suffering or at risk of suffering from an injury to renal function, reduced renal function, and/or acute renal failure.
Opening claim text (preview).
We claim: 1 . A method for evaluating renal status in a subject, comprising: determining a measured value for one or more of a urine TIMP2 concentration and a urine IGFBP7 concentration; determining a measured value for one or more of a serum creatinine concentration and a urine output; combining the measured values obtained into a single value to provide an assay result; and correlating the assay result to the renal status of the subject, wherein said correlation step comprises correlating the assay result(s) to one or more of diagnosis, risk stratification, prognosis, classifying and monitoring of the renal status of the subject.
Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP · CPC title
Insulin-like growth factor binding protein · CPC title
ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding · CPC title
Staging of a disease; Further complications associated with the disease · CPC title
Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.